chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nasal congestion, Nausea, Pyrexia
Clinical narrative: Incredible headache; Congested; Fever; Nausea; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Congested), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Body aches) and HEADACHE (Incredible headache) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Headache. Previously administered products included for Product used for unknown indication: Janssen in May 2021. Past adverse reactions to the above products included No adverse event with Janssen.    On 15-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. On 16-Dec-2021, the patient experienced NASAL CONGESTION (Congested), PYREXIA (Fever), NAUSEA (Nausea) and MYALGIA (Body aches). On 20-Dec-2021, the patient experienced HEADACHE (Incredible headache). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and XYLOMETAZOLINE HYDROCHLORIDE (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (Congested), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Body aches) and HEADACHE (Incredible headache) outcome was unknown.            No concomitant medication provided.
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (got 0.25mls booster dose Moderna covid vax on 3rd Nov, but this was her first dose, should have been 0.5mls) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 03-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (got 0.25mls booster dose Moderna covid vax on 3rd Nov, but this was her first dose, should have been 0.5mls). On 03-Nov-2021, ACCIDENTAL UNDERDOSE (got 0.25mls booster dose Moderna covid vax on 3rd Nov, but this was her first dose, should have been 0.5mls) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Charley-horse; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Charley-horse) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV infection (undetectable HIV).   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Charley-horse). At the time of the report, MUSCLE SPASMS (Charley-horse) outcome was unknown.            No Concomitant product use was reported.  The patient experienced charley-horse post receiving their second dose. Reportedly, the patient stated they had a past medical history of undetectable HIV.  No treatment information was provided.   This case was linked to MOD-2021-419311, MOD-2021-419280 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash pruritic
Clinical narrative: Intensive itching rash; Rash travelled all over body to every part/Rash was also in ankles, and bottom of the feet; Worst itching in torso and back; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Intensive itching rash), RASH (Rash travelled all over body to every part/Rash was also in ankles, and bottom of the feet) and PRURITUS (Worst itching in torso and back) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025D21A, 039K20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In December 2021, the patient experienced RASH PRURITIC (Intensive itching rash), RASH (Rash travelled all over body to every part/Rash was also in ankles, and bottom of the feet) and PRURITUS (Worst itching in torso and back). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) for Itchy, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itchy, at an unspecified dose and frequency. In December 2021, RASH PRURITIC (Intensive itching rash), RASH (Rash travelled all over body to every part/Rash was also in ankles, and bottom of the feet) and PRURITUS (Worst itching in torso and back) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Since patient did not change anything in daily life, thinks that the vaccine might have caused it. About the events Patient said that it has been 2 weeks but 3 days ago it started to subside and now patient is okay. No concomitant medications were mentioned.   This case was linked to MOD-2021-419372 (Patient Link).
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: A child was given his first dose of the Moderna covid-19 vaccine by intramuscular injection on 20DEC2021 (lot number 030H21B, expiration date 23MAR2022, 0.25mL); Inappropriate dose of vaccine administered (0.25 mL); This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A child was given his first dose of the Moderna covid-19 vaccine by intramuscular injection on 20DEC2021 (lot number 030H21B, expiration date 23MAR2022, 0.25mL)) and INCORRECT DOSE ADMINISTERED (Inappropriate dose of vaccine administered (0.25 mL)) in a 7-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 20-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A child was given his first dose of the Moderna covid-19 vaccine by intramuscular injection on 20DEC2021 (lot number 030H21B, expiration date 23MAR2022, 0.25mL)) and INCORRECT DOSE ADMINISTERED (Inappropriate dose of vaccine administered (0.25 mL)). On 20-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A child was given his first dose of the Moderna covid-19 vaccine by intramuscular injection on 20DEC2021 (lot number 030H21B, expiration date 23MAR2022, 0.25mL)) and INCORRECT DOSE ADMINISTERED (Inappropriate dose of vaccine administered (0.25 mL)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter. The patient had no symptoms nor had any medications or treatments.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: her dermatologist says that his mom is also having problems with pain in her shins & feet after getting the Moderna Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her dermatologist says that his mom is also having problems with pain in her shins & feet after getting the Moderna Vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (her dermatologist says that his mom is also having problems with pain in her shins & feet after getting the Moderna Vaccine). At the time of the report, PAIN IN EXTREMITY (her dermatologist says that his mom is also having problems with pain in her shins & feet after getting the Moderna Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Extremely itchy; Full body rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Extremely itchy) and RASH (Full body rash) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F21A, 030L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Dec-2021, the patient experienced PRURITUS (Extremely itchy) and RASH (Full body rash). At the time of the report, PRURITUS (Extremely itchy) and RASH (Full body rash) had not resolved.            Concomitant medications were not provided. Treatment information includes patient's Primary care physician gave her steroid and allergy pill (antihistamine).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Muscle tightness, Rash pruritic
Clinical narrative: A rash all over their body that was itchy; Muscles in their leg got really really tight; Could not walk for 3 days; This spontaneous case was reported by a nurse and describes the occurrence of RASH PRURITIC (A rash all over their body that was itchy), MUSCLE TIGHTNESS (Muscles in their leg got really really tight) and GAIT DISTURBANCE (Could not walk for 3 days) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939903, 007M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, the patient experienced MUSCLE TIGHTNESS (Muscles in their leg got really really tight) and GAIT DISTURBANCE (Could not walk for 3 days). On 07-Dec-2021, the patient experienced RASH PRURITIC (A rash all over their body that was itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (A rash all over their body that was itchy) outcome was unknown and MUSCLE TIGHTNESS (Muscles in their leg got really really tight) and GAIT DISTURBANCE (Could not walk for 3 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Other treatment information includes resting, drinking plenty of fluids and topical cream.  Reporter stated that patient had no other symptoms and had no new products or no new medication added to their routine.
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: got a rash, mostly on my back; This spontaneous case was reported by a consumer and describes the occurrence of RASH (got a rash, mostly on my back) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (got a rash, mostly on my back). At the time of the report, RASH (got a rash, mostly on my back) outcome was unknown.            No Concomitant Drug details were reported.  No Treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue, Feeling cold, Headache
Clinical narrative: she woke up with a buzzing noise from head; vomiting,; ache-ness to the point where she can't bend down; felt like her back was broke; incredibly cold; nausea; feverish; very tired; soreness in arm too; soreness; aches/soreness; she had chills; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke) and FEELING COLD (incredibly cold) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Pfizer (left deltoid) on 19-Mar-2021 and Pfizer (left deltoid) on 09-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke), FEELING COLD (incredibly cold), NAUSEA (nausea), PYREXIA (feverish), FATIGUE (very tired), VACCINATION SITE PAIN (soreness in arm too), MYALGIA (soreness), MYALGIA (aches/soreness), CHILLS (she had chills) and HEADACHE (bad headache). On 19-Dec-2021, TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke), FEELING COLD (incredibly cold), NAUSEA (nausea), PYREXIA (feverish), FATIGUE (very tired), VACCINATION SITE PAIN (soreness in arm too), MYALGIA (soreness), MYALGIA (aches/soreness), CHILLS (she had chills) and HEADACHE (bad headache) had resolved.            No concomitant medications provided. No treatment medications provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Myalgia, Nausea, Pyrexia, Tinnitus
Clinical narrative: she woke up with a buzzing noise from head; vomiting,; ache-ness to the point where she can't bend down; felt like her back was broke; incredibly cold; nausea; feverish; very tired; soreness in arm too; soreness; aches/soreness; she had chills; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke) and FEELING COLD (incredibly cold) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Pfizer (left deltoid) on 19-Mar-2021 and Pfizer (left deltoid) on 09-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke), FEELING COLD (incredibly cold), NAUSEA (nausea), PYREXIA (feverish), FATIGUE (very tired), VACCINATION SITE PAIN (soreness in arm too), MYALGIA (soreness), MYALGIA (aches/soreness), CHILLS (she had chills) and HEADACHE (bad headache). On 19-Dec-2021, TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke), FEELING COLD (incredibly cold), NAUSEA (nausea), PYREXIA (feverish), FATIGUE (very tired), VACCINATION SITE PAIN (soreness in arm too), MYALGIA (soreness), MYALGIA (aches/soreness), CHILLS (she had chills) and HEADACHE (bad headache) had resolved.            No concomitant medications provided. No treatment medications provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: she woke up with a buzzing noise from head; vomiting,; ache-ness to the point where she can't bend down; felt like her back was broke; incredibly cold; nausea; feverish; very tired; soreness in arm too; soreness; aches/soreness; she had chills; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke) and FEELING COLD (incredibly cold) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Pfizer (left deltoid) on 19-Mar-2021 and Pfizer (left deltoid) on 09-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke), FEELING COLD (incredibly cold), NAUSEA (nausea), PYREXIA (feverish), FATIGUE (very tired), VACCINATION SITE PAIN (soreness in arm too), MYALGIA (soreness), MYALGIA (aches/soreness), CHILLS (she had chills) and HEADACHE (bad headache). On 19-Dec-2021, TINNITUS (she woke up with a buzzing noise from head), VOMITING (vomiting,), BACK PAIN (ache-ness to the point where she can't bend down), MUSCULOSKELETAL DISCOMFORT (felt like her back was broke), FEELING COLD (incredibly cold), NAUSEA (nausea), PYREXIA (feverish), FATIGUE (very tired), VACCINATION SITE PAIN (soreness in arm too), MYALGIA (soreness), MYALGIA (aches/soreness), CHILLS (she had chills) and HEADACHE (bad headache) had resolved.            No concomitant medications provided. No treatment medications provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash pruritic
Clinical narrative: intensive itching rash/it travelled all over my body, every part; worst itching in torso and back; rash in ankles and bottom of the feet; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (intensive itching rash/it travelled all over my body, every part), PRURITUS (worst itching in torso and back) and RASH (rash in ankles and bottom of the feet) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (intensive itching rash/it travelled all over my body, every part), PRURITUS (worst itching in torso and back) and RASH (rash in ankles and bottom of the feet). At the time of the report, RASH PRURITIC (intensive itching rash/it travelled all over my body, every part), PRURITUS (worst itching in torso and back) and RASH (rash in ankles and bottom of the feet) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information ascend cream (might have steroids) was provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site joint pain, Vaccination site pain
Clinical narrative: pain in the left arm, shoulder and elbow, it hurts intermittently; pain in the left arm/still hurting; could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep), VACCINATION SITE JOINT PAIN (pain in the left arm, shoulder and elbow, it hurts intermittently) and VACCINATION SITE PAIN (pain in the left arm/still hurting) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 032M20A) for COVID-19 vaccination.     The patient's past medical history included Thyroidectomy (patient had thyroid procedure done, thus taking thyroid medication.).   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced VACCINATION SITE JOINT PAIN (pain in the left arm, shoulder and elbow, it hurts intermittently) and VACCINATION SITE PAIN (pain in the left arm/still hurting). In 2021, the patient experienced INSOMNIA (could not sleep). At the time of the report, INSOMNIA (could not sleep) outcome was unknown and VACCINATION SITE JOINT PAIN (pain in the left arm, shoulder and elbow, it hurts intermittently) and VACCINATION SITE PAIN (pain in the left arm/still hurting) had not resolved.            Concomitant drug included thyroid medication. No medication, no treatment given.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose is given 2 weeks after the first; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is given 2 weeks after the first) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is given 2 weeks after the first). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is given 2 weeks after the first) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: How intense is the side effect of second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (How intense is the side effect of second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (How intense is the side effect of second dose). At the time of the report, VACCINATION COMPLICATION (How intense is the side effect of second dose) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: I had the chills; I was tired for a day; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (I had the chills) and FATIGUE (I was tired for a day) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20 and 012L20A) for COVID-19 vaccination.     The patient's past medical history included Hormone replacement therapy in January 2015. Concurrent medical conditions included Cholesterolosis NOS since January 2000, Heart disorder since January 2015, Eye disorder since September 2008 and Bone disorder since January 2015. Concomitant products included COLECALCIFEROL, MENAQUINONE (D3 +K2) for Bone disorder (NOS), MONASCUS PURPUREUS (RED YEAST RICE) for Cholesterolosis NOS, XANTOFYL, ZEAXANTHIN (I CAPS) for Eye disorder NOS, UBIDECARENONE (COQ-10) for Heart disorder, ESTRADIOL BENZOATE (ESTRADIOL [ESTRADIOL BENZOATE]) for Hormone replacement therapy.   On 08-Jan-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (I had the chills) and FATIGUE (I was tired for a day). At the time of the report, CHILLS (I had the chills) and FATIGUE (I was tired for a day) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-419421, MOD-2021-399886 (Patient Link).
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Had a shingles rash about 7 weeks ago; This spontaneous case was reported by a pharmacist and describes the occurrence of HERPES ZOSTER (Had a shingles rash about 7 weeks ago) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Had a shingles rash about 7 weeks ago). At the time of the report, HERPES ZOSTER (Had a shingles rash about 7 weeks ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant and Treatment medication were reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Body temperature, Chills, Illness
Clinical narrative: Felt very sick after booster; Stomach pain; Weakness; Fever (101F); Chills; Body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt very sick after booster), ABDOMINAL PAIN UPPER (Stomach pain), ASTHENIA (Weakness), PYREXIA (Fever (101F)) and CHILLS (Chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A, 001B21A and 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Dec-2021, the patient experienced ILLNESS (Felt very sick after booster), ABDOMINAL PAIN UPPER (Stomach pain), ASTHENIA (Weakness), PYREXIA (Fever (101F)), CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, ILLNESS (Felt very sick after booster) had not resolved and ABDOMINAL PAIN UPPER (Stomach pain), ASTHENIA (Weakness), PYREXIA (Fever (101F)), CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Dec-2021, Body temperature: 101 (High) 101 F.         No concomitant medication was reported by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: Felt very sick after booster; Stomach pain; Weakness; Fever (101F); Chills; Body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt very sick after booster), ABDOMINAL PAIN UPPER (Stomach pain), ASTHENIA (Weakness), PYREXIA (Fever (101F)) and CHILLS (Chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A, 001B21A and 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Dec-2021, the patient experienced ILLNESS (Felt very sick after booster), ABDOMINAL PAIN UPPER (Stomach pain), ASTHENIA (Weakness), PYREXIA (Fever (101F)), CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, ILLNESS (Felt very sick after booster) had not resolved and ABDOMINAL PAIN UPPER (Stomach pain), ASTHENIA (Weakness), PYREXIA (Fever (101F)), CHILLS (Chills), MYALGIA (Body aches) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Dec-2021, Body temperature: 101 (High) 101 F.         No concomitant medication was reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose administered beyond authorized interval.; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered beyond authorized interval.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered beyond authorized interval.). In July 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered beyond authorized interval.) had resolved.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Myalgia
Clinical narrative: 3 nosebleeds since her booster dose with one as recently as this morning; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (3 nosebleeds since her booster dose with one as recently as this morning) and MYALGIA (Body aches) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced EPISTAXIS (3 nosebleeds since her booster dose with one as recently as this morning) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) in December 2021 for Myalgia, at an unspecified dose and frequency. In December 2021, MYALGIA (Body aches) had resolved. At the time of the report, EPISTAXIS (3 nosebleeds since her booster dose with one as recently as this morning) outcome was unknown.            No concomitant medication were reported by the reporter.   This case was linked to MOD-2021-419496, MOD-2021-419500 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Myalgia, at an unspecified dose and frequency. At the time of the report, MYALGIA (Body aches) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant product use was provided.   This case was linked to MOD-2021-419483, MOD-2021-419500 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Had body aches with the 1st two shot; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Had body aches with the 1st two shot) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Had body aches with the 1st two shot). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Myalgia, at an unspecified dose and frequency. At the time of the report, MYALGIA (Had body aches with the 1st two shot) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.   This case was linked to MOD-2021-419483, MOD-2021-419496 (Patient Link).
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Pain in extremity, Somnolence
Clinical narrative: Soreness in the arm; Just wants to sleep all the time; Strong body aches; Completely worn out; Joint aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm), SOMNOLENCE (Just wants to sleep all the time), MYALGIA (Strong body aches), FATIGUE (Completely worn out) and ARTHRALGIA (Joint aches) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Soreness in the arm). In December 2021, the patient experienced SOMNOLENCE (Just wants to sleep all the time), MYALGIA (Strong body aches), FATIGUE (Completely worn out) and ARTHRALGIA (Joint aches). At the time of the report, PAIN IN EXTREMITY (Soreness in the arm), SOMNOLENCE (Just wants to sleep all the time), MYALGIA (Strong body aches), FATIGUE (Completely worn out) and ARTHRALGIA (Joint aches) outcome was unknown.            No concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-419551, MOD-2021-419562 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Developed a full body rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Developed a full body rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced RASH (Developed a full body rash). At the time of the report, RASH (Developed a full body rash) outcome was unknown.            Concomitant drugs were not reported. Treatment medications were not provided.  It was reported that 8-9 days after vaccination patient develop full body rash.   Reporter did not allow further contact
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: light side effects from the first two doses.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (light side effects from the first two doses.) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION COMPLICATION (light side effects from the first two doses.). At the time of the report, VACCINATION COMPLICATION (light side effects from the first two doses.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is on concomitant medication, but did not specify which ones. No treatment medication reported   This case was linked to MOD-2021-419522, MOD-2021-419562 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: minor injection site reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (minor injection site reaction) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (minor injection site reaction). At the time of the report, VACCINATION SITE REACTION (minor injection site reaction) outcome was unknown.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Bad sick for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Bad sick for 2 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Bad sick for 2 days). At the time of the report, ILLNESS (Bad sick for 2 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  It was reported that, due to the event, mother of the patient had to go and stay with her daughter.   This case was linked to MOD-2021-418877 (Patient Link).   Reporter did not allow further contact
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 13-year-old son inadvertently received Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13-year-old son inadvertently received Moderna COVID-19 vaccine) in a 13-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13-year-old son inadvertently received Moderna COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13-year-old son inadvertently received Moderna COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.  The patient was supposed to get Pfizer COVID-19 vaccine.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: doses were administered on 31st day after moving the vaccine from freezer to fridge; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were administered on 31st day after moving the vaccine from freezer to fridge) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were administered on 31st day after moving the vaccine from freezer to fridge). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were administered on 31st day after moving the vaccine from freezer to fridge) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Received the booster yesterday of 0.25 mcg; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Received the booster yesterday of 0.25 mcg) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 mcg. On 19-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (Received the booster yesterday of 0.25 mcg). On 19-Dec-2021, ACCIDENTAL UNDERDOSE (Received the booster yesterday of 0.25 mcg) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: a little nausea; severe body aches for about 6 hours; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (a little nausea) and MYALGIA (severe body aches for about 6 hours) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (a little nausea) and MYALGIA (severe body aches for about 6 hours). At the time of the report, NAUSEA (a little nausea) outcome was unknown and MYALGIA (severe body aches for about 6 hours) had resolved.            No concomitant medication and treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Facial pain, Pyrexia, Toothache
Clinical narrative: Pain in face; teeth hurt a lot; severe pain under her armpits; mild fever; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (Pain in face), TOOTHACHE (teeth hurt a lot), AXILLARY PAIN (severe pain under her armpits) and PYREXIA (mild fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FACIAL PAIN (Pain in face), TOOTHACHE (teeth hurt a lot), AXILLARY PAIN (severe pain under her armpits) and PYREXIA (mild fever). At the time of the report, FACIAL PAIN (Pain in face), TOOTHACHE (teeth hurt a lot), AXILLARY PAIN (severe pain under her armpits) and PYREXIA (mild fever) outcome was unknown.            No concomitant medications reported by reporter No treatment medications provided by the reporter.